glp-1 inhibitors How Receptor Agonists Evolved from Diabetes Treatments to Weight Loss Treatments GLP-1 Costs Explained: Managing Coverage

Since retatrutide has gotten a lot of attention, some people are trying to get it outside of approved medical channels

Drugs of Today

Meta-analyses show green tea catechins produce approximately 2-3 pounds of additional weight loss over 12 weeks compared to placebo

Waumans Y, Baerts L, Kehoe K, Lambeir AM, De Meester I

Final Thoughts With new weight loss treatments on the horizon, theres never been a better time to seek a trusted provider who understands the full picture

Here, we report the design and target validation of EP45, a chimeric dual agonist peptide that has the surprising ability to act as an agonist at both the glucagon-like peptide-1 receptor (GLP-1R) and the neuropeptide Y 2 receptor (NPY2R)